Starbloom Capital is a venture capital firm investing in breakthrough innovations in deep tech, including longevity biotech, neuroAI, life sciences, and emerging industries. The firm partners with visionary founders pushing the frontiers of science and technology.
They made 4 investments in the last 12 months. Average disclosed round size is $32.9M (across 13 rounds with reported amounts).
Portfolio
12
Fund Size
—
Top Stage
Seed
Last 12 Mo
4
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Cognito | Series C | $105M | Mar 2026 |
 Adaptyx Biosciences | Seed | $14M | Oct 2025 |
| AAdaptyx | Seed | $14M | Oct 2025 |
 Bexorg | Series A | $23M | Oct 2025 |
 0xbow | Seed | $3.5M | Jan 2025 |
 LIFT | Series A | — | Sep 2024 |
 Cognito Therapeutics | Series B | $73M | Mar 2023 |
| Cognito | Series B | $73M | Mar 2023 |
 TBD Health | Seed | $4.4M | Jan 2023 |
 Rysk | Pre-Seed | $1.4M | — |
 Sablier | Pre-Seed | $500K | — |
 Elastrin | Unknown | $10M | — |
 Rysk Finance | Pre-Seed | $1.4M | — |
| Cognito Therapeutics | Series C | $105M | — |
Top Co-Investors
IAG Capital Partners3 shared
Yunt Capital2 shared
Ascensive Assets2 shared
Lemniscap2 shared
Seaside Equity Partners2 shared
Interlagos2 shared
Cantos2 shared
Overwater Ventures2 shared
Stanford University2 shared
Hyperlink Ventures2 shared
WS Investment Company2 shared
Apollo Health Ventures2 shared
Morningside2 shared
Rev1 Ventures1 shared
Engine Ventures1 shared
Amplify Partners1 shared
Connecticut Innovations1 shared
Business Angel1 shared
Balaji Srinivasan1 shared
Last updated: 20 October 2026